Loading...
•
Jun 30, 2021
Medpace Q2 2021 Earnings Report
Medpace's revenue increased, driven by net new business awards and backlog conversion.
Key Takeaways
Medpace Holdings, Inc. reported a strong second quarter in 2021, with revenue increasing by 35.8% to $278.3 million compared to the prior-year period. Net new business awards grew by 52.5% to $387.6 million, resulting in a net book-to-bill ratio of 1.39x. GAAP net income increased to $39.9 million, or $1.06 per diluted share, compared to $24.1 million, or $0.64 per diluted share, in the prior-year period.
Revenue for Q2 2021 increased 35.8% to $278.3 million compared to Q2 2020.
Net new business awards were $387.6 million in Q2 2021, a 52.5% increase year-over-year.
GAAP net income for Q2 2021 was $39.9 million, or $1.06 per diluted share, compared to $24.1 million, or $0.64 per diluted share, for the comparable prior-year period.
Cash and cash equivalents were $339.0 million as of June 30, 2021, and the company generated $62.8 million in cash flow from operating activities during the second quarter of 2021.
Forward Guidance
The Company forecasts 2021 revenue in the range of $1.110 billion to $1.150 billion, representing growth of 19.9% to 24.2% over 2020 revenue of $925.9 million. GAAP net income for full year 2021 is forecasted in the range of $162.5 million to $169.5 million. Additionally, full year 2021 EBITDA is expected in the range of $205.0 million to $215.0 million. Based on forecasted 2021 revenue of $1.110 billion to $1.150 billion and GAAP net income of $162.5 million to $169.5 million, diluted earnings per share (GAAP) is forecasted in the range of $4.31 to $4.50.
Positive Outlook
- Revenue is forecasted between $1.110 billion and $1.150 billion.
- Revenue growth of 19.9% to 24.2% over 2020 revenue.
- GAAP net income is forecasted between $162.5 million and $169.5 million.
- EBITDA is expected to be in the range of $205.0 million to $215.0 million.
- Diluted earnings per share (GAAP) is forecasted in the range of $4.31 to $4.50.
Challenges Ahead
- Guidance assumes a full year 2021 tax rate of 11.0% to 12.0%.
- Guidance does not reflect the potential impact of any share repurchases the Company may make pursuant to the share repurchase program after June 30, 2021.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...